Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Dec. 31, 2014 | Jan. 23, 2015 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Booz Allen Hamilton Holding Corp | |
Entity Central Index Key | 1443646 | |
Document Type | 10-Q | |
Document Period End Date | 31-Dec-14 | |
Amendment Flag | FALSE | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q3 | |
Current Fiscal Year End Date | -28 | |
Entity Filer Category | Large Accelerated Filer | |
Common stock, Class A | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 147,908,527 | |
Non-voting common stock, Class B | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 0 | |
Restricted common stock, Class C | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 0 | |
Special voting common stock, Class E | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 1,851,590 |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (USD $) | Dec. 31, 2014 | Mar. 31, 2014 |
In Thousands, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $197,443 | $259,994 |
Accounts receivable, net of allowance | 844,745 | 916,737 |
Prepaid expenses and other current assets | 112,358 | 79,246 |
Total current assets | 1,154,546 | 1,255,977 |
Property and equipment, net of accumulated depreciation | 105,537 | 129,427 |
Intangible assets, net of accumulated amortization | 222,373 | 220,887 |
Goodwill | 1,299,370 | 1,273,789 |
Other long-term assets | 50,244 | 60,738 |
Total assets | 2,832,070 | 2,940,818 |
Current liabilities: | ||
Current portion of long-term debt | 51,875 | 73,688 |
Accounts payable and other accrued expenses | 438,022 | 488,807 |
Accrued compensation and benefits | 292,184 | 331,440 |
Other current liabilities | 26,774 | 23,169 |
Total current liabilities | 808,855 | 917,104 |
Long-term debt, net of current portion | 1,584,069 | 1,585,231 |
Other long-term liabilities | 243,897 | 266,847 |
Total liabilities | 2,636,821 | 2,769,182 |
Commitments and contingencies (Note 16) | ||
Stockholders’ equity: | ||
Treasury stock, at cost — 1,986,626 shares at December 31, 2014 and 609,625 shares at March 31, 2014 | -43,522 | -10,153 |
Additional paid-in capital | 163,381 | 144,269 |
Retained earnings | 80,264 | 42,688 |
Accumulated other comprehensive loss | -6,379 | -6,636 |
Total stockholders’ equity | 195,249 | 171,636 |
Total liabilities and stockholders’ equity | 2,832,070 | 2,940,818 |
Common stock, Class A | ||
Stockholders’ equity: | ||
Common stock | 1,499 | 1,440 |
Non-voting common stock, Class B | ||
Stockholders’ equity: | ||
Common stock | 0 | 6 |
Restricted common stock, Class C | ||
Stockholders’ equity: | ||
Common stock | 0 | 9 |
Special voting common stock, Class E | ||
Stockholders’ equity: | ||
Common stock | $6 | $13 |
Condensed_Consolidated_Balance1
Condensed Consolidated Balance Sheets (Parenthetical) (USD $) | Dec. 31, 2014 | Mar. 31, 2014 |
Treasury stock, shares | 1,986,626 | 609,625 |
Common stock, Class A | ||
Common stock, par value | 0.01 | 0.01 |
Common stock, shares authorized | 600,000,000 | 600,000,000 |
Common stock, shares issued | 149,895,153 | 143,962,073 |
Common stock, shares outstanding | 147,908,527 | 143,352,448 |
Non-voting common stock, Class B | ||
Common stock, par value | 0.01 | 0.01 |
Common stock, shares authorized | 16,000,000 | 16,000,000 |
Common stock, shares issued | 0 | 582,080 |
Common stock, shares outstanding | 0 | 582,080 |
Restricted common stock, Class C | ||
Common stock, par value | 0.01 | 0.01 |
Common stock, shares authorized | 5,000,000 | 5,000,000 |
Common stock, shares issued | 0 | 935,871 |
Common stock, shares outstanding | 0 | 935,871 |
Special voting common stock, Class E | ||
Common stock, par value | 0.003 | 0.003 |
Common stock, shares authorized | 25,000,000 | 25,000,000 |
Common stock, shares issued | 1,851,589 | 4,424,814 |
Common stock, shares outstanding | 1,851,589 | 4,424,814 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Operations (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 |
Income Statement [Abstract] | ||||
Revenue | $1,304,686 | $1,273,150 | $3,931,824 | $4,078,861 |
Operating costs and expenses: | ||||
Cost of revenue | 641,541 | 662,053 | 1,928,967 | 2,048,663 |
Billable expenses | 366,371 | 320,370 | 1,064,994 | 1,083,890 |
General and administrative expenses | 176,327 | 175,748 | 524,368 | 520,557 |
Depreciation and amortization | 15,191 | 17,945 | 47,233 | 54,377 |
Total operating costs and expenses | 1,199,430 | 1,176,116 | 3,565,562 | 3,707,487 |
Operating income | 105,256 | 97,034 | 366,262 | 371,374 |
Interest expense | -17,863 | -18,874 | -54,544 | -59,761 |
Other, net | -777 | 21 | -1,080 | -1,619 |
Income before income taxes | 86,616 | 78,181 | 310,638 | 309,994 |
Income tax expense | 33,809 | 31,014 | 121,432 | 124,701 |
Net income | $52,807 | $47,167 | $189,206 | $185,293 |
Earnings per common share (Note 3): | ||||
Basic (in dollars per share) | $0.35 | $0.32 | $1.28 | $1.31 |
Diluted (in dollars per share) | $0.35 | $0.31 | $1.24 | $1.24 |
Dividends declared per share | $0.11 | $1.10 | $1.33 | $1.30 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $52,807 | $47,167 | $189,206 | $185,293 |
Change in postretirement plan costs, net of tax | 86 | 419 | 257 | 1,952 |
Comprehensive income | $52,893 | $47,586 | $189,463 | $187,245 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Cash flows from operating activities | ||
Net income | $189,206 | $185,293 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 47,233 | 54,377 |
Stock-based compensation expense | 19,954 | 14,119 |
Excess tax benefits from the exercise of stock options | -48,452 | -36,844 |
Amortization of debt issuance costs and loss on extinguishment | 9,538 | 9,444 |
Losses on dispositions and impairments | 1,396 | 911 |
Changes in assets and liabilities: | ||
Accounts receivable | 73,088 | 140,785 |
Prepaid expenses and other current assets | 15,008 | 19,963 |
Other long-term assets | 773 | -1,679 |
Accrued compensation and benefits | -31,390 | -25,824 |
Accounts payable and other accrued expenses | -56,419 | -15,619 |
Accrued interest | 7,467 | -630 |
Other current liabilities | 1,582 | -48,610 |
Other long-term liabilities | -926 | -3,352 |
Net cash provided by operating activities | 228,058 | 292,334 |
Cash flows from investing activities | ||
Purchases of property and equipment | 17,466 | 12,344 |
Cash paid for business acquisitions, net of cash acquired | 23,907 | -3,563 |
Escrow receipts | 0 | -3,282 |
Net cash used in investing activities | -41,373 | -5,499 |
Cash flows from financing activities | ||
Net proceeds from issuance of common stock | 3,699 | 3,785 |
Stock option exercises | 4,272 | 12,773 |
Excess tax benefits from the exercise of stock options | 48,452 | 36,844 |
Repurchases of common stock | -33,369 | -2,935 |
Cash dividends paid | 195,924 | 186,828 |
Dividend equivalents paid to option holders | -47,006 | -52,065 |
Debt issuance costs | -8,610 | -6,223 |
Repayment of debt | -219,188 | -289,406 |
Proceeds from debt issuance | 198,438 | 250,000 |
Net cash used in financing activities | -249,236 | -234,055 |
Net (decrease) increase in cash and cash equivalents | -62,551 | 52,780 |
Cash and cash equivalents-beginning of period | 259,994 | 350,384 |
Cash and cash equivalents-end of period | 197,443 | 403,164 |
Cash paid during the period for: | ||
Interest | 36,552 | 46,927 |
Income taxes | $114,276 | $140,893 |
Business_Overview
Business Overview | 9 Months Ended |
Dec. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BUSINESS OVERVIEW | BUSINESS OVERVIEW |
Organization | |
Booz Allen Hamilton Holding Corporation, including its wholly owned subsidiaries, or Holding or the Company, is an affiliate of The Carlyle Group, or Carlyle, and was incorporated in Delaware in May 2008. The Company provides management consulting, technology, and engineering services to the U.S. government in the defense, intelligence, and civil markets. Additionally, the Company provides its management and technology consulting services to major corporations, institutions, and not-for-profit organizations. The Company reports operating results and financial data in one operating segment. The Company is headquartered in McLean, Virginia, with approximately 22,300 employees as of December 31, 2014. |
Basis_of_Presentation
Basis of Presentation | 9 Months Ended |
Dec. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BASIS OF PRESENTATION | BASIS OF PRESENTATION |
The Company prepared the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q, or Quarterly Report, in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The Company followed the accounting policies used and disclosed in the consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended March 31, 2014 filed with the Securities and Exchange Commission on May 22, 2014, or Annual Report, and policies stated within this Quarterly Report. The Company’s fiscal year ends on March 31 and unless otherwise noted, references to fiscal year or fiscal are for fiscal years ended March 31. | |
The interim financial information in this Quarterly Report reflects all adjustments, consisting of normal recurring adjustments except as otherwise disclosed, necessary for a fair presentation of the Company’s results of operations for the interim periods. The results of operations for the nine months ended December 31, 2014 are not necessarily indicative of results to be expected for the full fiscal year. | |
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Areas of the financial statements where estimates may have the most significant effect include allowance for doubtful accounts, contractual and regulatory reserves, valuation and lives of tangible and intangible assets, contingent consideration related to business acquisitions, impairment of long-lived assets, accrued liabilities, revenue recognition, bonus and other incentive compensation, stock-based compensation, realization of deferred tax assets, provisions for income taxes, and postretirement obligations. Actual results experienced by the Company may differ materially from management's estimates. | |
Recent Accounting Pronouncements | |
In May 2014, the Financial Accounting Standards Board issued a new standard that will replace existing revenue recognition standards and significantly expand the disclosure requirements for revenue arrangements. The new standard will be effective for the Company beginning on April 1, 2017 (i.e., beginning with the first quarter fiscal 2018 interim financial statements). The new standard may be adopted retrospectively for all periods presented, or adopted using a modified retrospective approach. Under the retrospective approach, the fiscal 2017 and 2016 financial statements would be adjusted to reflect the effects of applying the new standard on those periods. Under the modified retrospective approach, the new standard would only be applied for the period beginning April 1, 2017 to new contracts and those contracts that are not yet complete at April 1, 2017, with a cumulative catch-up adjustment recorded to beginning retained earnings for existing contracts that still require performance. Management is still in the process of determining which transition method to utilize in order to apply the new standard and still assessing what effect the application of this standard may have on the timing of our revenue recognition and our financial statements. | |
Other recent accounting pronouncements issued by the FASB during the nine months ended December 31, 2014 and through the filing date did not or are not believed by management to have a material impact on the Company's present or historical condensed consolidated financial statements. |
Earnings_Per_Share
Earnings Per Share | 9 Months Ended | |||||||||||||||
Dec. 31, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||
EARNINGS PER SHARE | EARNINGS PER SHARE | |||||||||||||||
The Company computes basic and diluted earnings per share amounts based on net income for the periods presented. The Company uses the weighted average number of common shares outstanding during the period to calculate basic earnings per share, or EPS. Diluted EPS adjusts the weighted average number of shares outstanding to include the dilutive effect of outstanding common stock options and other stock-based awards. | ||||||||||||||||
The Company currently has outstanding shares of Class A Common Stock and Class E Special Voting Common Stock. During the three months ended September 30, 2014, the Company converted all issued and outstanding shares of Class B Non-Voting Common Stock and Class C Restricted Common Stock into shares of Class A Common Stock on a one-for-one basis. Class E Special Voting Common Stock shares are not included in the calculation of EPS as these shares represent voting rights only and are not entitled to participate in dividends or other distributions. Unvested Class A Restricted Common Stock holders are entitled to participate in non-forfeitable dividends or other distributions. These unvested shares participated in the Company's dividends declared and paid in the first, second, and third quarters of fiscal 2015 and 2014. As such, EPS is calculated using the two-class method whereby earnings are reduced by distributed earnings as well as any available undistributed earnings allocable to holders of unvested restricted shares. A reconciliation of the income used to compute basic and diluted EPS for the periods presented are as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Earnings for basic computations (1) | $ | 52,010 | $ | 45,689 | $ | 186,275 | $ | 183,605 | ||||||||
Weighted-average Class A Common Stock outstanding | 146,664,977 | 140,948,396 | 144,482,223 | 138,540,878 | ||||||||||||
Weighted-average Class B Non-Voting Common Stock outstanding | 0 | 947,259 | 293,071 | 1,087,755 | ||||||||||||
Weighted-average Class C Restricted Common Stock outstanding | 0 | 968,405 | 504,112 | 1,042,537 | ||||||||||||
Total weighted-average common shares outstanding for basic computations | 146,664,977 | 142,864,060 | 145,279,406 | 140,671,170 | ||||||||||||
Earnings for diluted computations (1) | $ | 52,025 | $ | 45,689 | $ | 186,275 | $ | 183,605 | ||||||||
Dilutive stock options and restricted stock | 4,014,108 | 5,971,223 | 4,960,430 | 7,494,020 | ||||||||||||
Average number of common shares outstanding for diluted computations | 150,679,085 | 148,835,283 | 150,239,836 | 148,165,190 | ||||||||||||
Earnings per common share | ||||||||||||||||
Basic | $ | 0.35 | $ | 0.32 | $ | 1.28 | $ | 1.31 | ||||||||
Diluted | $ | 0.35 | $ | 0.31 | $ | 1.24 | $ | 1.24 | ||||||||
(1) During the three months ended December 31, 2014 and 2013, approximately 2.2 million and 1.3 million participating securities were paid dividends totaling $250,000 and $1.5 million, respectively. During the nine months ended December 31, 2014 and 2013, approximately 2.2 million and 1.3 million participating securities were paid dividends totaling $2.9 million and $1.7 million, respectively. For the three months ended December 31, 2014 there were undistributed earnings of $550,000 and $540,000 allocated to the participating class of securities in basic and diluted earnings per share, respectively. The allocated undistributed earnings and the dividends paid comprise the difference between net income presented on the condensed consolidated statements of operations for the three months ended December 31, 2014 and earnings for basic computations, while only the dividends paid comprise the difference in net income for the three months ended December 31, 2013, and nine months ended December 31, 2014 and 2013 as there were no undistributed earnings. | ||||||||||||||||
The EPS calculation for the three and nine months ended December 31, 2014 excludes 100,000 and 302,000 options, respectively, as their impact was anti-dilutive. The EPS calculation for the three and nine months ended December 31, 2013 excludes 101,000 and 104,000 options, respectively, as their impact was anti-dilutive. |
Accounts_Receivable_Net
Accounts Receivable, Net | 9 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Receivables [Abstract] | ||||||||
ACCOUNTS RECEIVABLE, NET | ACCOUNTS RECEIVABLE, NET | |||||||
Accounts receivable, net consisted of the following: | ||||||||
December 31, | March 31, | |||||||
2014 | 2014 | |||||||
Current | ||||||||
Accounts receivable–billed | $ | 378,691 | $ | 395,509 | ||||
Accounts receivable–unbilled | 466,450 | 522,685 | ||||||
Allowance for doubtful accounts | (396 | ) | (1,457 | ) | ||||
Accounts receivable, net | 844,745 | 916,737 | ||||||
Long-term | ||||||||
Unbilled receivables | 18,284 | 22,877 | ||||||
Total accounts receivable, net | $ | 863,029 | $ | 939,614 | ||||
Unbilled amounts represent sales for which billings have not been presented to customers at quarter-end or year-end. These amounts are usually billed and collected within one year. Long-term unbilled receivables not anticipated to be billed and collected within one year, which are primarily related to retainage, holdbacks, and long-term rate settlements to be billed at contract closeout, are included in other long-term assets as accounts receivable in the accompanying condensed consolidated balance sheets. The Company recognized a provision (benefit) for doubtful accounts (including certain unbilled reserves) of $(8,000) and $(302,000) for the three months ended December 31, 2014 and 2013, respectively, and $(987,000) and $1.2 million for the nine months ended December 31, 2014 and 2013, respectively. Because the Company's accounts receivable are primarily with the U.S. Government and its agencies, the Company does not have material exposure to accounts receivable credit risk. |
Accounts_Payable_and_Other_Acc
Accounts Payable and Other Accrued Expenses | 9 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Payables and Accruals [Abstract] | |||||||||
ACCOUNTS PAYABLE AND OTHER ACCRUED EXPENSES | ACCOUNTS PAYABLE AND OTHER ACCRUED EXPENSES | ||||||||
Accounts payable and other accrued expenses consisted of the following: | |||||||||
December 31, | March 31, | ||||||||
2014 | 2014 | ||||||||
Vendor payables | $ | 201,438 | $ | 265,079 | |||||
Accrued expenses | 236,584 | 223,728 | |||||||
Total accounts payable and other accrued expenses | $ | 438,022 | $ | 488,807 | |||||
Accrued expenses consisted primarily of the Company’s reserve related to potential cost disallowance in conjunction with government audits. Refer to Note 16 for further discussion of this reserve. |
Accrued_Compensation_and_Benef
Accrued Compensation and Benefits | 9 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Accrued Compensation and Benefits [Abstract] | ||||||||
ACCRUED COMPENSATION AND BENEFITS | ACCRUED COMPENSATION AND BENEFITS | |||||||
Accrued compensation and benefits consisted of the following: | ||||||||
December 31, | March 31, | |||||||
2014 | 2014 | |||||||
Bonus | $ | 61,135 | $ | 75,423 | ||||
Retirement | 71,702 | 43,405 | ||||||
Vacation | 99,533 | 117,626 | ||||||
Stock-based compensation liability (Note 13) | 31,738 | 39,922 | ||||||
Deferred compensation | — | 27,547 | ||||||
Other | 28,076 | 27,517 | ||||||
Total accrued compensation and benefits | $ | 292,184 | $ | 331,440 | ||||
Debt
Debt | 9 Months Ended | |||||||||||||
Dec. 31, 2014 | ||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||
DEBT | DEBT | |||||||||||||
Debt consisted of the following: | ||||||||||||||
December 31, 2014 | March 31, 2014 | |||||||||||||
Interest | Outstanding | Interest | Outstanding | |||||||||||
Rate | Balance | Rate | Balance | |||||||||||
Term Loan A | 2.66 | % | $ | 806,193 | 2.65 | % | $ | 660,317 | ||||||
Term Loan B | 3.75 | % | 829,751 | 3.75 | % | 998,602 | ||||||||
Total | 1,635,944 | 1,658,919 | ||||||||||||
Less: Current portion of long-term debt | (51,875 | ) | (73,688 | ) | ||||||||||
Long-term debt, net of current portion | $ | 1,584,069 | $ | 1,585,231 | ||||||||||
On May 7, 2014, the Company entered into the Second Amendment to the Credit Agreement, dated as of July 31, 2012 (as previously amended by the First Amendment to the Credit Agreement, dated as of August 16, 2013). As of December 31, 2014, the Credit Agreement, as amended, provided the Company with an $830.0 million Term Loan A and an $841.2 million Term Loan B, and a $500.0 million revolving credit facility, with a sublimit for letters of credit of $100.0 million. The outstanding obligations under the Credit Agreement, as amended, are secured by a security interest in substantially all of the assets of the Company, subject to certain exceptions set forth in the Credit Agreement, as amended, and related documentation. The rates for Term Loan A and Term Loan B, as amended, remain unchanged. The Second Amendment also extended the maturity date of Term Loan A and the revolving credit facility to May 31, 2019. The maturity date for Term Loan B remained unchanged. The Company also amended its existing debt covenants to provide for greater operational and financial flexibility. | ||||||||||||||
The Credit Agreement, as amended, requires quarterly principal payments of 1.25% of the stated principal amount of Term Loan A, with annual incremental increases to 1.875%, 2.50%, 3.125%, and 13.0%, prior to Term Loan A's maturity date of May 31, 2019. As a result of paying approximately $168.4 million of Term Loan B principal in connection with the Second Amendment, no additional principal payments are required until the remaining balance is due on Term Loan B's maturity date of July 31, 2019. The revolving credit facility matures on May 31, 2019, at which time any outstanding principal balance is due in full. As of December 31, 2014 and March 31, 2014, there were no amounts outstanding on the revolving credit facility. | ||||||||||||||
The interest rate on borrowings under Term Loan A is LIBOR plus a 2.50% spread. The spread ranges from 2.00% to 2.75% based on the Company's total leverage ratio. The interest rate on borrowings under Term Loan B is LIBOR plus a 3.0% spread with a 0.75% floor. The spread ranges from 2.00% to 3.00% based upon either an ABR or LIBOR borrowing. The revolving credit facility margin and commitment fee are subject to the leveraged based pricing grid, as set forth in the Credit Agreement, as amended. | ||||||||||||||
The total outstanding debt balance is recorded in the accompanying condensed consolidated balance sheets, net of unamortized discount of $14.5 million and $12.3 million as of December 31, 2014 and March 31, 2014, respectively. | ||||||||||||||
As of December 31, 2014 and March 31, 2014, the Company was in compliance with all of the Credit Agreement's debt covenants. |
Income_Taxes
Income Taxes | 9 Months Ended |
Dec. 31, 2014 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES |
The Company’s effective income tax rate was 39.0% and 39.7% for the three months ended December 31, 2014 and 2013, respectively, and 39.1% and 40.2% for the nine months ended December 31, 2014 and 2013, respectively. The three and nine months effective tax rates of 39.0% and 39.1% differ from the statutory rate of 35.0% due to state income taxes and the effect of permanent rate differences, which primarily relate to meals and entertainment. |
Other_LongTerm_Liabilities
Other Long-Term Liabilities | 9 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Other Liabilities Disclosure [Abstract] | |||||||||
OTHER LONG-TERM LIABILITIES | OTHER LONG-TERM LIABILITIES | ||||||||
Other long-term liabilities consisted of the following: | |||||||||
December 31, | March 31, | ||||||||
2014 | 2014 | ||||||||
Income tax reserve | $ | 57,949 | $ | 57,406 | |||||
Deferred rent | 24,416 | 28,527 | |||||||
Stock-based compensation liability (Note 13) | — | 25,966 | |||||||
Deferred payment obligation | 59,679 | 60,444 | |||||||
Postretirement benefit obligations | 84,917 | 80,527 | |||||||
Other | 16,936 | 13,977 | |||||||
Total other long-term liabilities | $ | 243,897 | $ | 266,847 | |||||
As of December 31, 2014 and March 31, 2014, the Company recorded a stock-based compensation liability of $31.7 million and $65.9 million, respectively, including $31.7 million and $39.9 million, respectively, expected to be paid within one year, related to special dividends paid in July and December 2009, June and August 2012, November 2013, and February and August 2014. Rollover options vested and not yet exercised that would have had an exercise price below zero as a result of the dividends were reduced to one cent, with the remaining reduction to be paid in cash upon exercise of the options. Payments of the special dividends to the Company's Amended and Restated Equity Incentive Plan, or EIP, option holders is linked to vesting. Refer to Note 13 for further discussion of the special dividends. |
Employee_Benefit_Plans
Employee Benefit Plans | 9 Months Ended | |||||||||||||||
Dec. 31, 2014 | ||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ||||||||||||||||
EMPLOYEE BENEFIT PLANS | EMPLOYEE BENEFIT PLANS | |||||||||||||||
Defined Contribution Plan | ||||||||||||||||
The Company sponsors the Employees’ Capital Accumulation Plan, or ECAP, which is a qualified defined contribution plan that covers eligible U.S. and international employees. ECAP provides for distributions, subject to certain vesting provisions, to participants by reason of retirement, death, disability, or termination of employment. Effective April 1, 2014 the Company transitioned from a discretionary employer contribution to an annual matching contribution of up to 6% of eligible annual income as determined by the Internal Revenue Code for the ECAP. Total expense recognized under ECAP was $26.2 million and $36.4 million for the three months ended December 31, 2014 and 2013, respectively, and $81.4 million and $118.7 million for the nine months ended December 31, 2014 and 2013, respectively. The Company-paid contributions were $14.9 million and $19.3 million for the three months ended December 31, 2014 and 2013, respectively, and $53.1 million and $83.7 million for the nine months ended December 31, 2014 and 2013, respectively. | ||||||||||||||||
Defined Benefit Plan and Other Postretirement Benefit Plans | ||||||||||||||||
The Company maintains and administers a postretirement medical plan and a defined benefit retirement plan for current, retired, and resigned officers. | ||||||||||||||||
The components of net postretirement medical expense for the Officer Medical Plan were as follows: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Service cost | $ | 1,022 | $ | 1,186 | $ | 3,064 | $ | 3,559 | ||||||||
Interest cost | 892 | 921 | 2,676 | 2,751 | ||||||||||||
Net actuarial loss | 145 | 704 | 436 | 2,068 | ||||||||||||
Total postretirement medical expense | $ | 2,059 | $ | 2,811 | $ | 6,176 | $ | 8,378 | ||||||||
As of December 31, 2014 and March 31, 2014, the unfunded status of the post-retirement medical plan was $80.2 million and $75.9 million, respectively, which is included in other long-term liabilities in the accompanying condensed consolidated balance sheets. |
Accumulated_Other_Comprehensiv
Accumulated Other Comprehensive Loss | 9 Months Ended | |||||||||||||||
Dec. 31, 2014 | ||||||||||||||||
Equity [Abstract] | ||||||||||||||||
ACCUMULATED OTHER COMPREHENSIVE LOSS | ACCUMULATED OTHER COMPREHENSIVE LOSS | |||||||||||||||
All amounts recorded in other comprehensive loss are related to the Company's post-retirement plan. The following table represents a rollforward of amounts recognized in accumulated other comprehensive loss, net of tax: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Beginning of period | $ | (6,465 | ) | $ | (12,254 | ) | $ | (6,636 | ) | $ | (13,787 | ) | ||||
Other comprehensive income (loss) before reclassifications | — | — | — | 747 | ||||||||||||
Amounts reclassified from accumulated other comprehensive loss | 86 | 419 | 257 | 1,205 | ||||||||||||
Net current-period other comprehensive loss | 86 | 419 | 257 | 1,952 | ||||||||||||
End of period | $ | (6,379 | ) | $ | (11,835 | ) | $ | (6,379 | ) | $ | (11,835 | ) | ||||
The following table presents the reclassifications out of accumulated other comprehensive loss to net income: | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Amortization of net actuarial loss included in net periodic benefit cost (See Note 10) | ||||||||||||||||
Total before tax | $ | 144 | $ | 704 | $ | 432 | $ | 2,068 | ||||||||
Tax benefit | (58 | ) | (285 | ) | (175 | ) | (863 | ) | ||||||||
Net of tax | $ | 86 | $ | 419 | $ | 257 | $ | 1,205 | ||||||||
Stockholders_Equity
Stockholders' Equity | 9 Months Ended | ||||||||||||||
Dec. 31, 2014 | |||||||||||||||
Equity [Abstract] | |||||||||||||||
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY | ||||||||||||||
Common Stock | |||||||||||||||
The common stock shares activity consisted of the following: | |||||||||||||||
Class A | Class B | Class C | Class E | Treasury | |||||||||||
Common Stock | Non-Voting | Restricted | Special Voting | Stock | |||||||||||
Common Stock | Common Stock | Common Stock | |||||||||||||
Balance at March 31, 2013 | 136,457,444 | 1,451,600 | 1,224,319 | 7,478,522 | 405,843 | ||||||||||
Issuance of common stock | 1,047,160 | — | — | — | — | ||||||||||
Stock options exercised | 5,299,501 | — | — | -3,053,708 | — | ||||||||||
Share exchange | 1,157,968 | -869,520 | -288,448 | — | — | ||||||||||
Repurchase of common stock (1) | — | — | — | — | 203,782 | ||||||||||
Balance at March 31, 2014 | 143,962,073 | 582,080 | 935,871 | 4,424,814 | 609,625 | ||||||||||
Issuance of common stock | 1,315,400 | — | — | — | — | ||||||||||
Stock options exercised | 3,099,729 | — | — | (2,573,225 | ) | — | |||||||||
Share exchange (3) | 1,517,951 | -582,080 | -935,871 | — | — | ||||||||||
Repurchase of common stock (2) | — | — | — | — | 1,377,001 | ||||||||||
Balance at December 31, 2014 | 149,895,153 | — | — | 1,851,589 | 1,986,626 | ||||||||||
-1 | Reflects shares repurchased on June 30, 2013 to cover the minimum statutory withholding taxes on restricted stock awards that vested on June 30, 2013 and shares repurchased on multiple dates to cover the minimum statutory withholding taxes on accelerated restricted stock vesting for departing officers. | ||||||||||||||
-2 | On November 5, 2014, the Company entered into an agreement with an affiliate of The Carlyle Group to repurchase 1,000,000 shares of the Company's Class A Common Stock. The shares were repurchased at a price of $25.10 per share in a private non-underwritten transaction. The repurchase of common stock above also reflects shares repurchased on June 30, 2014 to cover the minimum statutory withholding taxes on restricted stock awards that vested on June 30, 2014, shares repurchased on September 12, 2014 to cover the minimum statutory withholding taxes on rollover stock options exercised on September 12, 2014 and shares repurchased on multiple dates to cover the minimum statutory withholding taxes on accelerated restricted stock vesting for departing officers. | ||||||||||||||
-3 | At the annual meeting of stockholders held on July 31, 2014, the stockholders approved a proposal to amend and restate the certificate of incorporation, which had the effect of converting all issued and outstanding shares of Class B Non-Voting Common Stock and Class C Restricted Common Stock into shares of Class A Common Stock on a one-for-one basis. The conversion was effected on August 13, 2014 when the Company filed its third amended and restated certificate of incorporation with the Secretary of State of the State of Delaware. As a result of the conversion, there were no shares of Class B Non-Voting Common Stock and Class C Restricted Common Stock outstanding at such time. | ||||||||||||||
For the quarterly offering period that closed on December 31, 2014, 48,029 Class A Common Stock shares were purchased by employees under the Company's Employee Stock Purchase Plan, or ESPP. Since the program's inception, 1,460,880 shares have been purchased by employees. |
StockBased_Compensation
Stock-Based Compensation | 9 Months Ended | |||||||||||||||||||||||
Dec. 31, 2014 | ||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION | |||||||||||||||||||||||
The following table summarizes stock-based compensation expense recognized in the condensed consolidated statements of operations: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
Cost of revenue | $ | 2,303 | $ | 1,322 | $ | 6,601 | $ | 3,982 | ||||||||||||||||
General and administrative expenses | 4,764 | 3,456 | 13,353 | 10,137 | ||||||||||||||||||||
Total | $ | 7,067 | $ | 4,778 | $ | 19,954 | $ | 14,119 | ||||||||||||||||
The following table summarizes the total stock-based compensation expense recognized in the condensed consolidated statements of operations by the following types of equity awards: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
Equity Incentive Plan Options | $ | 1,241 | $ | 1,790 | $ | 4,022 | $ | 4,741 | ||||||||||||||||
Class A Restricted Common Stock | 5,826 | 2,988 | 15,932 | 8,741 | ||||||||||||||||||||
Rollover Options | — | — | — | 578 | ||||||||||||||||||||
Class C Restricted Stock | — | — | — | 59 | ||||||||||||||||||||
Total | $ | 7,067 | $ | 4,778 | $ | 19,954 | $ | 14,119 | ||||||||||||||||
As of December 31, 2014, there was $34.6 million of total unrecognized compensation cost related to unvested stock-based compensation agreements. The unrecognized compensation cost as of December 31, 2014 is expected to be amortized over 4.25 years. Absent the effect of accelerating stock compensation cost for any departures of employees who may continue to vest in their equity awards, the following table summarizes the unrecognized compensation cost and the weighted average period the cost is expected to be amortized. | ||||||||||||||||||||||||
December 31, 2014 | ||||||||||||||||||||||||
Unrecognized Compensation Cost | Weighted Average Remaining Period to be Recognized | |||||||||||||||||||||||
Equity Incentive Plan Options | $ | 5,862 | 3.02 | |||||||||||||||||||||
Class A Restricted Common Stock | 28,723 | 2.9 | ||||||||||||||||||||||
Total | $ | 34,585 | ||||||||||||||||||||||
Equity Incentive Plan | ||||||||||||||||||||||||
On October 29, 2014, 34,766 options were granted under the EIP. The estimated fair value of the grant was $6.04, resulting in a total fair value of $0.2 million. The fair value of our Class A Common Stock on October 29, 2014 at the time of the option grant was $25.19. | ||||||||||||||||||||||||
On November 3, 2014, 65,310 options were granted under the EIP. The estimated fair value of the grant was $6.43, resulting in a total fair value of $0.4 million. The fair value of our Class A Common Stock on November 3, 2014 at the time of the option grant was $26.50. | ||||||||||||||||||||||||
As of December 31, 2014, there were 6,679,333 EIP options outstanding, of which 2,432,594 were unvested. | ||||||||||||||||||||||||
Grants of Class A Restricted Common Stock and Restricted Stock Units | ||||||||||||||||||||||||
There were no grants of Class A Restricted Stock or Restricted Stock Units during the three months ended December 31, 2014. | ||||||||||||||||||||||||
Special Dividends | ||||||||||||||||||||||||
The Board of Directors, as the Administrator of the Officers' Rollover Stock Plan and the EIP, has discretion in how to effect the required adjustment to keep option holders whole in the event of a distribution of dividends that triggers certain anti-dilution clauses within the respective plans. In the event the Board of Directors elects to grant option holders a cash payment equal to the amount of the special dividend, the Company accrues a stock-based compensation liability as the respective option's stock compensation expense is recorded in the condensed consolidated statement of operations. This obligation will be settled on the options' mandatory exercise date for Rollover options and on the later of the date the dividend is paid or vesting for the EIP options. The stock-based compensation liability includes all special dividends declared. | ||||||||||||||||||||||||
Total compensation expense recorded in conjunction with the payment of the dividend equivalents to EIP options holders for the three months ended December 31, 2014 was $0.1 million. Future compensation expense related to the payment of the dividend equivalents to holders of EIP options not yet recognized in the statement of operations is $0.6 million and is expected to be recognized over 2.50 years. | ||||||||||||||||||||||||
As of December 31, 2014 and March 31, 2014, the Company calculated a total recorded and unrecorded stock-based compensation liability of $36.3 million and $73.1 million, respectively, related to the special dividends paid in July and December 2009, June and August 2012, November 2013 and February and August 2014. The recorded stock-based compensation liability is as follows: | ||||||||||||||||||||||||
December 31, 2014 | March 31, 2014 | |||||||||||||||||||||||
EIP Options | Rollover Options | Total | EIP Options | Rollover Options | Total | |||||||||||||||||||
Current portion of liability (1) | $ | 3,703 | $ | 28,035 | $ | 31,738 | $ | 3,675 | $ | 36,247 | $ | 39,922 | ||||||||||||
Long-term portion of liability (2) | — | — | — | — | 25,966 | 25,966 | ||||||||||||||||||
$ | 3,703 | $ | 28,035 | $ | 31,738 | $ | 3,675 | $ | 62,213 | $ | 65,888 | |||||||||||||
(1) Included in accrued compensation and benefits (Note 6). | ||||||||||||||||||||||||
(2) Included in other long-term liabilities (Note 9). | ||||||||||||||||||||||||
As of December 31, 2014, $4.6 million related to EIP options will be recorded as liabilities as the options vest over the next 4.25 years. As of March 31, 2014, there was an unrecorded liability of $7.2 million related to EIP options. There is no unrecorded liability related to Rollover options as of December 31, 2014 or March 31, 2014, as the Rollover options are fully vested. |
Fair_Value_Measurements
Fair Value Measurements | 9 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Fair Value Disclosures [Abstract] | ||||||||
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS | |||||||
The accounting standard for fair value measurements establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: observable inputs such as quoted prices in active markets (Level 1); inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2); and unobservable inputs in which there is little or no market data, which requires the Company to develop its own assumptions (Level 3). | ||||||||
A financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The following tables set forth by level represent the fair value of the Company's cash and cash equivalents as of December 31, 2014. | ||||||||
Fair Value of Cash and Cash Equivalents as of December 31, 2014 | ||||||||
Level 1 | Level 2 | Level 3 | Total | |||||
Cash and cash equivalents | $48,005 | — | — | $48,005 | ||||
Money market funds (1) | — | $149,438 | — | $149,438 | ||||
Total cash and cash equivalents | $48,005 | $149,438 | — | $197,443 | ||||
The following table set forth by levels represents the fair value of the Company's cash and cash equivalents as of March 31, 2014. | ||||||||
Fair Value of Cash and Cash Equivalents | ||||||||
as of March 31, 2014 | ||||||||
Level 1 | Level 2 | Level 3 | Total | |||||
Cash and cash equivalents | $37,886 | — | — | $37,886 | ||||
Money market funds (1) | — | $222,108 | — | $222,108 | ||||
Total cash and cash equivalents | $37,886 | $222,108 | — | $259,994 | ||||
(1) Level two cash and cash equivalents are invested in money market funds that are intended to maintain a stable net asset value of $1.00 per share by investing in liquid, high quality U.S. dollar-denominated money market instruments. Depending on our short-term liquidity needs, we make regular transfers between money market funds and other cash equivalents. | ||||||||
The fair value of the Company's trade accounts receivable and accounts payable approximates its carrying value at December 31, 2014 and March 31, 2014 because of the short-term nature of these instruments. The fair value of the Company's debt instruments approximates its carrying value at December 31, 2014 and March 31, 2014. The fair value of debt is determined based on interest rates available for debt with terms and maturities similar to the Company's existing debt arrangements (Level 2 inputs). | ||||||||
On October 9, 2014, the Company entered into a contingent consideration arrangement in connection with a business acquisition. Under the arrangement, the Company agreed to pay up to a maximum of $9 million in cash to the seller if certain financial performance thresholds are achieved in calendar years 2016 and 2017. The fair value of the contingent consideration liability as of December 31, 2014 was $4.5 million and is a Level 3 fair value measurement recorded within other long-term liabilities. It was valued using a Monte Carlo simulation and the key input besides projected cash flows was volatility, estimated as 30% based on the asset volatility of comparable publicly-traded companies. An increase (decrease) in volatility in isolation would result in a lower (higher) fair value measurement. After the initial recording of this liability as a part of the purchase accounting, there were no subsequent changes in fair value recorded during the third quarter of fiscal 2015. Any future changes in the fair value of this contingent consideration liability will be recognized in earnings during the applicable period. |
RelatedParty_Transactions
Related-Party Transactions | 9 Months Ended |
Dec. 31, 2014 | |
Related Party Transactions [Abstract] | |
RELATED-PARTY TRANSACTIONS | RELATED-PARTY TRANSACTIONS |
The Carlyle Group is the largest shareholder of the Company. On November 5, 2014, the Company entered into an agreement with an affiliate of The Carlyle Group to repurchase 1,000,000 shares of our Class A common stock pursuant to the repurchase program described in Note 12 above. The shares were repurchased at a price of $25.10 per share as part of a private non-underwritten transaction. From time to time, and in the ordinary course of business: (1) other Carlyle portfolio companies engage the Company as a subcontractor or service provider, and (2) the Company engages other Carlyle portfolio companies as subcontractors or service providers. Revenue and cost associated with these related parties for the three months ended December 31, 2014 were $312,000 and $233,000, respectively, and $961,000 and $719,000 for the nine months ended December 31, 2014, respectively. Revenue and cost associated with these related parties for the three months ended December 31, 2013 were $70,000 and $61,000, respectively, and $237,000 and $201,000 for the nine months ended December 31, 2013, respectively. | |
In addition, investment vehicles affiliated with The Carlyle Group participated in a lender syndicate in the Company’s outstanding debt in the amounts of $47.0 million and $55.5 million at December 31, 2014 and March 31, 2014, respectively. The participation by such investment vehicles in the syndication of the Company's debt was done on an arm’s length basis. | |
On July 31, 2008, the Company entered into a management agreement, or Management Agreement, with TC Group V US, L.L.C., or TC Group, a company affiliated with Carlyle. On June 7, 2012, TC Group assigned all of its right, title and interest in, and obligations under, the management agreement to Carlyle Investment Management L.L.C., or Carlyle Investment Management. In accordance with the Management Agreement, Carlyle Investment Management provides the Company with advisory, consulting, and other services and the Company pays Carlyle Investment Management an aggregate annual fee of $1.0 million, plus expenses. For the three months ended December 31, 2014 and 2013, the Company incurred $250,000 in advisory fees. For the nine months ended December 31, 2014 and 2013, the Company incurred $750,000 in advisory fees in each period. |
Commitments_and_Contingencies
Commitments and Contingencies | 9 Months Ended |
Dec. 31, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES |
Leases | |
As a result of the July 2008 acquisition, as described in the Company’s Annual Report, the Company assigned a total of nine leases to Booz & Co, which has subsequently changed its name to Strategy&. The Company remains liable for two leases for facilities located in Chicago and London under the terms of the original leases should Strategy& default on its obligations. All other leases assigned to Strategy& have expired. There were no events of default under these leases as of December 31, 2014 or March 31, 2014. The maximum potential amount of undiscounted future payments is $10.6 million, and the leases expire in November 2015 and March 2017. Based on the Company’s assessment of the likelihood of future payment, no amounts have been recorded related to the Company’s contingent liability on such leases. | |
Government Contracting Matters | |
For the three and nine months ended December 31, 2014, approximately 97% and 98%, respectively, of the Company’s revenue was generated from contracts with U.S. government agencies or other U.S. government contractors, and approximately 98% for the three and nine months ended December 31, 2013. Contracts with the U.S. government are subject to extensive legal and regulatory requirements and, from time to time and in the ordinary course of business, agencies of the U.S. government investigate whether the Company’s operations are conducted in accordance with these requirements and the terms of the relevant contracts by using investigative techniques such as subpoenas or civil investigative demands. U.S. government investigations of the Company, whether related to the Company’s U.S. government contracts or conducted for other reasons, could result in administrative, civil, or criminal liabilities, including repayments, fines, or penalties being imposed upon the Company, or could lead to suspension or debarment from future U.S. government contracting. Management believes it has adequately reserved for any losses that may be experienced from any investigation of which it is aware. The Defense Contract Management Agency Administrative Contracting Officer has negotiated annual final indirect cost rates through fiscal year 2007. Audits of subsequent years may result in cost reductions and/or penalties. Management believes it has adequately reserved for any losses that may be experienced from any such reductions and/or penalties. As of December 31, 2014 and March 31, 2014, the Company has recorded a liability of approximately $200.0 million and $189.8 million, respectively, for its current best estimate of amounts to be refunded to customers for potential adjustments from such audits or reviews of contract costs incurred subsequent to fiscal year 2007. | |
Litigation | |
The Company is involved in legal proceedings and investigations arising in the ordinary course of business, including those relating to employment matters, relationships with clients and contractors, intellectual property disputes, and other business matters. These legal proceedings seek various remedies, including claims for monetary damages in varying amounts that currently range up to $40 million or are unspecified as to amount. Although the outcome of any such matter is inherently uncertain and may be materially adverse, based on current information, management does not expect any of the currently ongoing audits, reviews, investigations, or litigation to have a material adverse effect on the Company’s financial condition and results of operations. As of December 31, 2014, there are no material amounts accrued in the condensed consolidated financial statements related to these proceedings. | |
Six former officers and stockholders who had departed the firm prior to July 31, 2008, the date on which we became majority owned by Carlyle and certain of its affiliated investment funds, as described in the Company’s Annual Report, or the Acquisition, have filed a total of nine suits in various jurisdictions, with original filing dates ranging from July 3, 2008 through December 15, 2009 (three of which were amended on July 2, 2010 and then further amended into one consolidated complaint on September 7, 2010) against the Company and certain of the Company’s current and former directors and officers. Each of the suits arises out of the Acquisition and alleges that the former stockholders are entitled to certain payments that they would have received if they had held their stock at the time of the Acquisition. Some of the suits also allege that the Acquisition price paid to stockholders was insufficient. The various suits assert claims for breach of contract, tortious interference with contract, breach of fiduciary duty, civil Racketeer Influenced and Corrupt Organizations Act, or RICO, violations, violations of the Employee Retirement Income Security Act, and/or securities and common law fraud. Three of these suits have been dismissed with all appeals exhausted. One of the remaining suits has been dismissed by the United States District Court for the Southern District of California and is on appeal before the United States Court of Appeals for the Ninth Circuit. The other five remaining suits are pending in the United States District Court for the Southern District of New York. As of December 31, 2014 and March 31, 2014, the aggregate alleged damages sought in the six remaining suits was approximately $348.7 million ($291.5 million of which is sought to be trebled pursuant to RICO) plus punitive damages, costs, and fees. Although the outcome of any of these cases is inherently uncertain and may be materially adverse, based on current information, management does not expect them to have a material adverse effect on our financial condition and results of operations. |
Subsequent_Events_Subsequent_E
Subsequent Events Subsequent Events | 9 Months Ended |
Dec. 31, 2014 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS |
On January 27, 2015, the Board of Directors approved an increase to our share repurchase authorization from $30.0 million to up to $180.0 million. |
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 9 Months Ended | |||||||||||||||
Dec. 31, 2014 | ||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||
Reconciliation of the income used to compute basic and diluted EPS | A reconciliation of the income used to compute basic and diluted EPS for the periods presented are as follows: | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Earnings for basic computations (1) | $ | 52,010 | $ | 45,689 | $ | 186,275 | $ | 183,605 | ||||||||
Weighted-average Class A Common Stock outstanding | 146,664,977 | 140,948,396 | 144,482,223 | 138,540,878 | ||||||||||||
Weighted-average Class B Non-Voting Common Stock outstanding | 0 | 947,259 | 293,071 | 1,087,755 | ||||||||||||
Weighted-average Class C Restricted Common Stock outstanding | 0 | 968,405 | 504,112 | 1,042,537 | ||||||||||||
Total weighted-average common shares outstanding for basic computations | 146,664,977 | 142,864,060 | 145,279,406 | 140,671,170 | ||||||||||||
Earnings for diluted computations (1) | $ | 52,025 | $ | 45,689 | $ | 186,275 | $ | 183,605 | ||||||||
Dilutive stock options and restricted stock | 4,014,108 | 5,971,223 | 4,960,430 | 7,494,020 | ||||||||||||
Average number of common shares outstanding for diluted computations | 150,679,085 | 148,835,283 | 150,239,836 | 148,165,190 | ||||||||||||
Earnings per common share | ||||||||||||||||
Basic | $ | 0.35 | $ | 0.32 | $ | 1.28 | $ | 1.31 | ||||||||
Diluted | $ | 0.35 | $ | 0.31 | $ | 1.24 | $ | 1.24 | ||||||||
(1) During the three months ended December 31, 2014 and 2013, approximately 2.2 million and 1.3 million participating securities were paid dividends totaling $250,000 and $1.5 million, respectively. During the nine months ended December 31, 2014 and 2013, approximately 2.2 million and 1.3 million participating securities were paid dividends totaling $2.9 million and $1.7 million, respectively. For the three months ended December 31, 2014 there were undistributed earnings of $550,000 and $540,000 allocated to the participating class of securities in basic and diluted earnings per share, respectively. The allocated undistributed earnings and the dividends paid comprise the difference between net income presented on the condensed consolidated statements of operations for the three months ended December 31, 2014 and earnings for basic computations, while only the dividends paid comprise the difference in net income for the three months ended December 31, 2013, and nine months ended December 31, 2014 and 2013 as there were no undistributed earnings |
Accounts_Receivable_Net_Accoun
Accounts Receivable, Net Account Receivable, Net (Tables) | 9 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Receivables [Abstract] | ||||||||
Accounts receivable, net | Accounts receivable, net consisted of the following: | |||||||
December 31, | March 31, | |||||||
2014 | 2014 | |||||||
Current | ||||||||
Accounts receivable–billed | $ | 378,691 | $ | 395,509 | ||||
Accounts receivable–unbilled | 466,450 | 522,685 | ||||||
Allowance for doubtful accounts | (396 | ) | (1,457 | ) | ||||
Accounts receivable, net | 844,745 | 916,737 | ||||||
Long-term | ||||||||
Unbilled receivables | 18,284 | 22,877 | ||||||
Total accounts receivable, net | $ | 863,029 | $ | 939,614 | ||||
Accounts_Payable_and_Other_Acc1
Accounts Payable and Other Accrued Expenses (Tables) | 9 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Payables and Accruals [Abstract] | |||||||||
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] | Accounts payable and other accrued expenses consisted of the following: | ||||||||
December 31, | March 31, | ||||||||
2014 | 2014 | ||||||||
Vendor payables | $ | 201,438 | $ | 265,079 | |||||
Accrued expenses | 236,584 | 223,728 | |||||||
Total accounts payable and other accrued expenses | $ | 438,022 | $ | 488,807 | |||||
Accrued_Compensation_and_Benef1
Accrued Compensation and Benefits (Tables) | 9 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Accrued Compensation and Benefits [Abstract] | ||||||||
Accrued compensation and benefits | Accrued compensation and benefits consisted of the following: | |||||||
December 31, | March 31, | |||||||
2014 | 2014 | |||||||
Bonus | $ | 61,135 | $ | 75,423 | ||||
Retirement | 71,702 | 43,405 | ||||||
Vacation | 99,533 | 117,626 | ||||||
Stock-based compensation liability (Note 13) | 31,738 | 39,922 | ||||||
Deferred compensation | — | 27,547 | ||||||
Other | 28,076 | 27,517 | ||||||
Total accrued compensation and benefits | $ | 292,184 | $ | 331,440 | ||||
Debt_Tables
Debt (Tables) | 9 Months Ended | |||||||||||||
Dec. 31, 2014 | ||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||
Debt | Debt consisted of the following: | |||||||||||||
December 31, 2014 | March 31, 2014 | |||||||||||||
Interest | Outstanding | Interest | Outstanding | |||||||||||
Rate | Balance | Rate | Balance | |||||||||||
Term Loan A | 2.66 | % | $ | 806,193 | 2.65 | % | $ | 660,317 | ||||||
Term Loan B | 3.75 | % | 829,751 | 3.75 | % | 998,602 | ||||||||
Total | 1,635,944 | 1,658,919 | ||||||||||||
Less: Current portion of long-term debt | (51,875 | ) | (73,688 | ) | ||||||||||
Long-term debt, net of current portion | $ | 1,584,069 | $ | 1,585,231 | ||||||||||
Other_LongTerm_Liabilities_Tab
Other Long-Term Liabilities (Tables) | 9 Months Ended | ||||||||
Dec. 31, 2014 | |||||||||
Other Liabilities Disclosure [Abstract] | |||||||||
Other Long-Term Liabilities | Other long-term liabilities consisted of the following: | ||||||||
December 31, | March 31, | ||||||||
2014 | 2014 | ||||||||
Income tax reserve | $ | 57,949 | $ | 57,406 | |||||
Deferred rent | 24,416 | 28,527 | |||||||
Stock-based compensation liability (Note 13) | — | 25,966 | |||||||
Deferred payment obligation | 59,679 | 60,444 | |||||||
Postretirement benefit obligations | 84,917 | 80,527 | |||||||
Other | 16,936 | 13,977 | |||||||
Total other long-term liabilities | $ | 243,897 | $ | 266,847 | |||||
Employee_Benefit_Plans_Tables
Employee Benefit Plans (Tables) | 9 Months Ended | |||||||||||||||
Dec. 31, 2014 | ||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | ||||||||||||||||
Components of net postretirement medical expense | The components of net postretirement medical expense for the Officer Medical Plan were as follows: | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Service cost | $ | 1,022 | $ | 1,186 | $ | 3,064 | $ | 3,559 | ||||||||
Interest cost | 892 | 921 | 2,676 | 2,751 | ||||||||||||
Net actuarial loss | 145 | 704 | 436 | 2,068 | ||||||||||||
Total postretirement medical expense | $ | 2,059 | $ | 2,811 | $ | 6,176 | $ | 8,378 | ||||||||
Accumulated_Other_Comprehensiv1
Accumulated Other Comprehensive Loss (Tables) | 9 Months Ended | |||||||||||||||
Dec. 31, 2014 | ||||||||||||||||
Equity [Abstract] | ||||||||||||||||
Schedule of accumulated other comprehensive loss | The following table represents a rollforward of amounts recognized in accumulated other comprehensive loss, net of tax: | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Beginning of period | $ | (6,465 | ) | $ | (12,254 | ) | $ | (6,636 | ) | $ | (13,787 | ) | ||||
Other comprehensive income (loss) before reclassifications | — | — | — | 747 | ||||||||||||
Amounts reclassified from accumulated other comprehensive loss | 86 | 419 | 257 | 1,205 | ||||||||||||
Net current-period other comprehensive loss | 86 | 419 | 257 | 1,952 | ||||||||||||
End of period | $ | (6,379 | ) | $ | (11,835 | ) | $ | (6,379 | ) | $ | (11,835 | ) | ||||
Reclassification out of accumulated other comprehensive loss to net income | The following table presents the reclassifications out of accumulated other comprehensive loss to net income: | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Amortization of net actuarial loss included in net periodic benefit cost (See Note 10) | ||||||||||||||||
Total before tax | $ | 144 | $ | 704 | $ | 432 | $ | 2,068 | ||||||||
Tax benefit | (58 | ) | (285 | ) | (175 | ) | (863 | ) | ||||||||
Net of tax | $ | 86 | $ | 419 | $ | 257 | $ | 1,205 | ||||||||
Stockholders_Equity_Tables
Stockholders' Equity (Tables) | 9 Months Ended | ||||||||||||||
Dec. 31, 2014 | |||||||||||||||
Equity [Abstract] | |||||||||||||||
Common stock shares activity | The common stock shares activity consisted of the following: | ||||||||||||||
Class A | Class B | Class C | Class E | Treasury | |||||||||||
Common Stock | Non-Voting | Restricted | Special Voting | Stock | |||||||||||
Common Stock | Common Stock | Common Stock | |||||||||||||
Balance at March 31, 2013 | 136,457,444 | 1,451,600 | 1,224,319 | 7,478,522 | 405,843 | ||||||||||
Issuance of common stock | 1,047,160 | — | — | — | — | ||||||||||
Stock options exercised | 5,299,501 | — | — | -3,053,708 | — | ||||||||||
Share exchange | 1,157,968 | -869,520 | -288,448 | — | — | ||||||||||
Repurchase of common stock (1) | — | — | — | — | 203,782 | ||||||||||
Balance at March 31, 2014 | 143,962,073 | 582,080 | 935,871 | 4,424,814 | 609,625 | ||||||||||
Issuance of common stock | 1,315,400 | — | — | — | — | ||||||||||
Stock options exercised | 3,099,729 | — | — | (2,573,225 | ) | — | |||||||||
Share exchange (3) | 1,517,951 | -582,080 | -935,871 | — | — | ||||||||||
Repurchase of common stock (2) | — | — | — | — | 1,377,001 | ||||||||||
Balance at December 31, 2014 | 149,895,153 | — | — | 1,851,589 | 1,986,626 | ||||||||||
-1 | Reflects shares repurchased on June 30, 2013 to cover the minimum statutory withholding taxes on restricted stock awards that vested on June 30, 2013 and shares repurchased on multiple dates to cover the minimum statutory withholding taxes on accelerated restricted stock vesting for departing officers. | ||||||||||||||
-2 | On November 5, 2014, the Company entered into an agreement with an affiliate of The Carlyle Group to repurchase 1,000,000 shares of the Company's Class A Common Stock. The shares were repurchased at a price of $25.10 per share in a private non-underwritten transaction. The repurchase of common stock above also reflects shares repurchased on June 30, 2014 to cover the minimum statutory withholding taxes on restricted stock awards that vested on June 30, 2014, shares repurchased on September 12, 2014 to cover the minimum statutory withholding taxes on rollover stock options exercised on September 12, 2014 and shares repurchased on multiple dates to cover the minimum statutory withholding taxes on accelerated restricted stock vesting for departing officers. | ||||||||||||||
-3 | At the annual meeting of stockholders held on July 31, 2014, the stockholders approved a proposal to amend and restate the certificate of incorporation, which had the effect of converting all issued and outstanding shares of Class B Non-Voting Common Stock and Class C Restricted Common Stock into shares of Class A Common Stock on a one-for-one basis. The conversion was effected on August 13, 2014 when the Company filed its third amended and restated certificate of incorporation with the Secretary of State of the State of Delaware. As a result of the conversion, there were no shares of Class B Non-Voting Common Stock and Class C Restricted Common Stock outstanding at such time. |
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 9 Months Ended | |||||||||||||||||||||||
Dec. 31, 2014 | ||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||
Stock-based compensation expense recognized in the condensed consolidated statements of operations | The following table summarizes stock-based compensation expense recognized in the condensed consolidated statements of operations: | |||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
Cost of revenue | $ | 2,303 | $ | 1,322 | $ | 6,601 | $ | 3,982 | ||||||||||||||||
General and administrative expenses | 4,764 | 3,456 | 13,353 | 10,137 | ||||||||||||||||||||
Total | $ | 7,067 | $ | 4,778 | $ | 19,954 | $ | 14,119 | ||||||||||||||||
The following table summarizes the total stock-based compensation expense recognized in the condensed consolidated statements of operations by the following types of equity awards: | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
Equity Incentive Plan Options | $ | 1,241 | $ | 1,790 | $ | 4,022 | $ | 4,741 | ||||||||||||||||
Class A Restricted Common Stock | 5,826 | 2,988 | 15,932 | 8,741 | ||||||||||||||||||||
Rollover Options | — | — | — | 578 | ||||||||||||||||||||
Class C Restricted Stock | — | — | — | 59 | ||||||||||||||||||||
Total | $ | 7,067 | $ | 4,778 | $ | 19,954 | $ | 14,119 | ||||||||||||||||
Schedule of unrecognized compensation cost | Absent the effect of accelerating stock compensation cost for any departures of employees who may continue to vest in their equity awards, the following table summarizes the unrecognized compensation cost and the weighted average period the cost is expected to be amortized. | |||||||||||||||||||||||
December 31, 2014 | ||||||||||||||||||||||||
Unrecognized Compensation Cost | Weighted Average Remaining Period to be Recognized | |||||||||||||||||||||||
Equity Incentive Plan Options | $ | 5,862 | 3.02 | |||||||||||||||||||||
Class A Restricted Common Stock | 28,723 | 2.9 | ||||||||||||||||||||||
Total | $ | 34,585 | ||||||||||||||||||||||
Recorded stock-based compensation liabilities | As of December 31, 2014 and March 31, 2014, the Company calculated a total recorded and unrecorded stock-based compensation liability of $36.3 million and $73.1 million, respectively, related to the special dividends paid in July and December 2009, June and August 2012, November 2013 and February and August 2014. The recorded stock-based compensation liability is as follows: | |||||||||||||||||||||||
December 31, 2014 | March 31, 2014 | |||||||||||||||||||||||
EIP Options | Rollover Options | Total | EIP Options | Rollover Options | Total | |||||||||||||||||||
Current portion of liability (1) | $ | 3,703 | $ | 28,035 | $ | 31,738 | $ | 3,675 | $ | 36,247 | $ | 39,922 | ||||||||||||
Long-term portion of liability (2) | — | — | — | — | 25,966 | 25,966 | ||||||||||||||||||
$ | 3,703 | $ | 28,035 | $ | 31,738 | $ | 3,675 | $ | 62,213 | $ | 65,888 | |||||||||||||
(1) Included in accrued compensation and benefits (Note 6). | ||||||||||||||||||||||||
(2) Included in other long-term liabilities (Note 9). |
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 9 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Fair Value Disclosures [Abstract] | ||||||||
Fair value of cash and cash equivalents | The following tables set forth by level represent the fair value of the Company's cash and cash equivalents as of December 31, 2014. | |||||||
Fair Value of Cash and Cash Equivalents as of December 31, 2014 | ||||||||
Level 1 | Level 2 | Level 3 | Total | |||||
Cash and cash equivalents | $48,005 | — | — | $48,005 | ||||
Money market funds (1) | — | $149,438 | — | $149,438 | ||||
Total cash and cash equivalents | $48,005 | $149,438 | — | $197,443 | ||||
The following table set forth by levels represents the fair value of the Company's cash and cash equivalents as of March 31, 2014. | ||||||||
Fair Value of Cash and Cash Equivalents | ||||||||
as of March 31, 2014 | ||||||||
Level 1 | Level 2 | Level 3 | Total | |||||
Cash and cash equivalents | $37,886 | — | — | $37,886 | ||||
Money market funds (1) | — | $222,108 | — | $222,108 | ||||
Total cash and cash equivalents | $37,886 | $222,108 | — | $259,994 | ||||
(1) Level two cash and cash equivalents are invested in money market funds that are intended to maintain a stable net asset value of $1.00 per share by investing in liquid, high quality U.S. dollar-denominated money market instruments. Depending on our short-term liquidity needs, we make regular transfers between money market funds and other cash equivalents. |
Business_Overview_Business_Ove
Business Overview Business Overview (Details) | Dec. 31, 2014 |
employees | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of employees | 22,300 |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | |
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||||
Earnings for basic computations | $52,010,000 | $45,689,000 | $186,275,000 | $183,605,000 |
Weighted-average common shares outstanding for basic computations | 146,664,977 | 142,864,060 | 145,279,406 | 140,671,170 |
Earnings for diluted computations | 52,025,000 | 45,689,000 | 186,275,000 | 183,605,000 |
Dilutive stock options and restricted stock | 4,014,108 | 5,971,223 | 4,960,430 | 7,494,020 |
Average number of common shares outstanding for diluted computations | 150,679,085 | 148,835,283 | 150,239,836 | 148,165,190 |
Earnings per common share, Basic | $0.35 | $0.32 | $1.28 | $1.31 |
Earnings per common share, Diluted | $0.35 | $0.31 | $1.24 | $1.24 |
Unvested shares, cash dividends paid | 47,006,000 | 52,065,000 | ||
Restricted stock | ||||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||||
Unvested shares participating in the payment of the Company's dividends declared | 2,200,000 | 1,300,000 | 2,200,000 | 1,300,000 |
Unvested shares, cash dividends paid | 300,000 | 1,500,000 | 2,900,000 | 1,700,000 |
Undistributed earnings allocated to participating securities, basic | 550,000 | 0 | 0 | 0 |
Undistributed earnings allocated to participating securities, diluted | $540,000 | $0 | $0 | $0 |
Stock options | ||||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||||
Antidilutive options excluded from the computation of EPS | 100,000 | 101,000 | 302,000 | 104,000 |
Common stock, Class A | ||||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||||
Weighted-average common shares outstanding for basic computations | 146,664,977 | 140,948,396 | 144,482,223 | 138,540,878 |
Non-voting common stock, Class B | ||||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||||
Weighted-average common shares outstanding for basic computations | 0 | 947,259 | 293,071 | 1,087,755 |
Restricted common stock, Class C | ||||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | ||||
Weighted-average common shares outstanding for basic computations | 0 | 968,405 | 504,112 | 1,042,537 |
Accounts_Receivable_Net_Acount
Accounts Receivable, Net Acounts Receivable, Net (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 |
Current | |||||
Accounts receivable–billed | $378,691 | $378,691 | $395,509 | ||
Accounts receivable–unbilled | 466,450 | 466,450 | 522,685 | ||
Allowance for doubtful accounts | -396 | -396 | -1,457 | ||
Accounts receivable, net | 844,745 | 844,745 | 916,737 | ||
Long-term | |||||
Unbilled receivables | 18,284 | 18,284 | 22,877 | ||
Total accounts receivable, net | 863,029 | 863,029 | 939,614 | ||
Provision for doubtful accounts | ($8) | ($302) | ($987) | $1,200 |
Accounts_Payable_and_Other_Acc2
Accounts Payable and Other Accrued Expenses (Details) (USD $) | Dec. 31, 2014 | Mar. 31, 2014 |
In Thousands, unless otherwise specified | ||
Payables and Accruals [Abstract] | ||
Vendor payables | $201,438 | $265,079 |
Accrued expenses | 236,584 | 223,728 |
Total accounts payable and other accrued expenses | $438,022 | $488,807 |
Accrued_Compensation_and_Benef2
Accrued Compensation and Benefits (Details) (USD $) | Dec. 31, 2014 | Mar. 31, 2014 |
In Thousands, unless otherwise specified | ||
Accrued Compensation and Benefits [Abstract] | ||
Bonus | $61,135 | $75,423 |
Retirement | 71,702 | 43,405 |
Vacation | 99,533 | 117,626 |
Stock-based compensation liability | 31,738 | 39,922 |
Deferred compensation | 0 | 27,547 |
Other | 28,076 | 27,517 |
Total accrued compensation and benefits | $292,184 | $331,440 |
Debt_Details
Debt (Details) (USD $) | 9 Months Ended | 0 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | 7-May-14 | Mar. 31, 2014 | |
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt | $1,635,944,000 | $1,658,919,000 | ||
Less: Current portion of long-term debt | -51,875,000 | -73,688,000 | ||
Long-term debt, net of current portion | 1,584,069,000 | 1,585,231,000 | ||
Repayment of debt | -219,188,000 | -289,406,000 | ||
Long-term debt, unamortized discount | 14,500,000 | 12,300,000 | ||
Secured Debt | Term Loan A | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Interest rate | 2.66% | 2.65% | ||
Long-term debt | 806,193,000 | 660,317,000 | ||
Term loan, face amount | 830,000,000 | |||
Quarterly periodic payment percentage, principal | 1.25% | |||
Quarterly principal periodic payment percentage, year two | 1.88% | |||
Quarterly principal periodic payment percentage, year three | 2.50% | |||
Quarterly principal periodic payment percentage, year four | 3.13% | |||
Quarterly principal periodic payment percentage, year five | 13.00% | |||
Secured Debt | Term Loan A | Minimum | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 2.00% | |||
Secured Debt | Term Loan A | Maximum | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 2.75% | |||
Secured Debt | Term Loan A | London Interbank Offered Rate (LIBOR) | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 2.50% | |||
Secured Debt | Term Loan B | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Interest rate | 3.75% | 3.75% | ||
Long-term debt | 829,751,000 | 998,602,000 | ||
Term loan, face amount | 841,200,000 | |||
Repayment of debt | -168,400,000 | |||
Secured Debt | Term Loan B | Minimum | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 0.75% | |||
Secured Debt | Term Loan B | London Interbank Offered Rate (LIBOR) | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 3.00% | |||
Secured Debt | Term Loan B | London Interbank Offered Rate (LIBOR) | Maximum | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 3.00% | |||
Secured Debt | Term Loan B | Alternative Base Rate (ABR) | Minimum | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Long-term debt, basis spread on variable rate | 2.00% | |||
Revolving Credit Facility | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Revolving credit facility, maximum borrowing capacity | 500,000,000 | |||
Revolving credit facility, amount outstanding | 0 | 0 | ||
Letter of Credit | ||||
Long-term Debt, Current and Noncurrent [Abstract] | ||||
Revolving credit facility, maximum borrowing capacity | $100,000,000 |
Income_Taxes_Details
Income Taxes (Details) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | |
Income Tax Disclosure [Abstract] | ||||
Effective income tax rate | 39.00% | 39.70% | 39.10% | 40.20% |
Statutory rate | 35.00% | 35.00% |
Other_LongTerm_Liabilities_Det
Other Long-Term Liabilities (Details) (USD $) | Dec. 31, 2014 | Mar. 31, 2014 |
Other Liabilities Disclosure [Abstract] | ||
Income tax reserve | $57,949,000 | $57,406,000 |
Deferred rent | 24,416,000 | 28,527,000 |
Stock-based compensation | 0 | 25,966,000 |
Deferred payment obligation | 59,679,000 | 60,444,000 |
Postretirement benefit obligations | 84,917,000 | 80,527,000 |
Other | 16,936,000 | 13,977,000 |
Total other long-term liabilities | 243,897,000 | 266,847,000 |
Stock-based compensation liability, current and noncurrent | 31,700,000 | 65,900,000 |
Stock-based compensation liability, current | $31,738,000 | $39,922,000 |
Employee_Benefit_Plans_Details
Employee Benefit Plans (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | |
Compensation and Retirement Disclosure [Abstract] | |||||
Employer Matching Contribution, Percent of Match | 6.00% | ||||
Employees’ Capital Accumulation Plan, Total expense recognized | $26,200,000 | $36,400,000 | $81,400,000 | $118,700,000 | |
Employees’ Capital Accumulation Plan, Company-paid contributions | 14,900,000 | 19,300,000 | 53,100,000 | 83,700,000 | |
Officer Medical Plan | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Service cost | 1,022,000 | 1,186,000 | 3,064,000 | 3,559,000 | |
Interest cost | 892,000 | 921,000 | 2,676,000 | 2,751,000 | |
Net actuarial loss | 145,000 | 704,000 | 436,000 | 2,068,000 | |
Total benefit cost | 2,059,000 | 2,811,000 | 6,176,000 | 8,378,000 | |
Defined benefit plan, unfunded status of plan | $80,200,000 | $80,200,000 | $75,900,000 |
Accumulated_Other_Comprehensiv2
Accumulated Other Comprehensive Loss (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Jun. 30, 2013 |
Equity [Abstract] | |||||
Beginning of year | ($6,465) | ($6,636) | ($13,787) | ($12,254) | |
Other comprehensive income (loss) before reclassifications | 0 | 0 | 0 | 747 | |
Amounts reclassified from accumulated other comprehensive loss | 86 | 419 | 257 | 1,205 | |
Net current-period other comprehensive loss | 86 | 419 | 257 | 1,952 | |
End of year | ($6,379) | ($11,835) | ($6,379) | ($11,835) | ($12,254) |
Accumulated_Other_Comprehensiv3
Accumulated Other Comprehensive Loss (Reclassifications out of Accumulated Other Comprehensive Loss to Net Income) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 |
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||||
Tax benefit | ($33,809) | ($31,014) | ($121,432) | ($124,701) |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment | ||||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||||
Total before tax | 144 | 704 | 432 | 2,068 |
Tax benefit | -58 | -285 | -175 | -863 |
Net of tax | $86 | $419 | $257 | $1,205 |
Stockholders_Equity_Common_Sto
Stockholders' Equity (Common Stock Shares Activity) (Details) (USD $) | 0 Months Ended | 9 Months Ended | 12 Months Ended |
Nov. 05, 2014 | Dec. 31, 2014 | Mar. 31, 2014 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
Treasury stock, shares, beginning of period | 609,625 | 405,843 | |
Repurchase of common stock | 1,000,000 | 1,377,001 | 203,782 |
Treasury stock, shares, end of period | 1,986,626 | 609,625 | |
Repurchase of common stock, price per share | $25.10 | ||
Common stock, Class A | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
Common stock, shares issued, beginning of period | 143,962,073 | 136,457,444 | |
Issuance of common stock | 1,315,400 | 1,047,160 | |
Stock options exercised | 3,099,729 | 5,299,501 | |
Share exchange | 1,517,951 | 1,157,968 | |
Common stock, shares issued, end of period | 149,895,153 | 143,962,073 | |
Non-voting common stock, Class B | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
Common stock, shares issued, beginning of period | 582,080 | 1,451,600 | |
Share exchange | -582,080 | -869,520 | |
Common stock, shares issued, end of period | 0 | 582,080 | |
Restricted common stock, Class C | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
Common stock, shares issued, beginning of period | 935,871 | 1,224,319 | |
Share exchange | -935,871 | -288,448 | |
Common stock, shares issued, end of period | 0 | 935,871 | |
Special voting common stock, Class E | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
Common stock, shares issued, beginning of period | 4,424,814 | 7,478,522 | |
Stock options exercised | -2,573,225 | -3,053,708 | |
Common stock, shares issued, end of period | 1,851,589 | 4,424,814 |
Stockholders_Equity_Employee_S
Stockholders' Equity (Employee Stock Purchase Plan) (Details) (USD $) | 9 Months Ended | 50 Months Ended |
In Millions, except Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Stock Repurchase Program, Authorized Amount | 30 | 30 |
Employee Stock Purchase Plan | Common stock, Class A | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares purchased by employees under the employee stock purchase plan | 48,029 | 1,460,880 |
StockBased_Compensation_Stockb
Stock-Based Compensation (Stock-based Compensation Expense) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | $7,067 | $4,778 | $19,954 | $14,119 |
Stock options | EIP | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 1,241 | 1,790 | 4,022 | 4,741 |
Stock options | Rollover Options | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 0 | 0 | 0 | 578 |
Restricted stock | Annual Incentive Plan | Common stock, Class A | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 5,826 | 2,988 | 15,932 | 8,741 |
Restricted stock | Rollover Options | Restricted common stock, Class C | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 0 | 0 | 0 | 59 |
Cost of revenue | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | 2,303 | 1,322 | 6,601 | 3,982 |
General and administrative expenses | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation expense | $4,764 | $3,456 | $13,353 | $10,137 |
StockBased_Compensation_Unreco
Stock-Based Compensation (Unrecognized Compensation) (Details) (USD $) | 9 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized compensation cost related to unvested stock-based compensation agreements | $34,585 |
Unrecognized compensation cost, amortization period | 4 years 3 months |
EIP | Stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized compensation cost related to unvested stock-based compensation agreements | 5,862 |
Unrecognized compensation cost, amortization period | 3 years 0 months 9 days |
Annual Incentive Plan | Restricted stock | Common stock, Class A | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Unrecognized compensation cost related to unvested stock-based compensation agreements | $28,723 |
Unrecognized compensation cost, amortization period | 2 years 10 months 23 days |
StockBased_Compensation_Stock_
Stock-Based Compensation (Stock Plans) (Details) (USD $) | 0 Months Ended | 3 Months Ended | |
In Millions, except Share data, unless otherwise specified | Nov. 03, 2014 | Oct. 29, 2014 | Dec. 31, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share Price | $26.50 | $25.19 | |
Stock options | EIP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 65,310 | 34,766 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $6.43 | $6.04 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants In Period, Fair Value | $0.40 | $0.20 | |
Stock options outstanding | 6,679,333 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number | 2,432,594 | ||
Common stock, Class A | Restricted stock | Annual Incentive Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 0 | ||
Common stock, Class A | Restricted Stock Units (RSUs) | Annual Incentive Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 0 |
StockBased_Compensation_Record
Stock-Based Compensation (Recorded and Unrecorded Stock-based Compensation Liability) (Details) (USD $) | 3 Months Ended | 9 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2014 | Mar. 31, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation liability, current | $31,738,000 | $31,738,000 | $39,922,000 |
Stock-based compensation liability, noncurrent | 0 | 0 | 25,966,000 |
Stock-based compensation liability, current and noncurrent | 31,700,000 | 31,700,000 | 65,900,000 |
Unrecognized compensation cost, amortization period | 4 years 3 months | ||
Special Cash Dividend | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Recorded and unrecorded stock-based compensation liability, current and noncurrent | 36,300,000 | 36,300,000 | 73,100,000 |
Stock options | EIP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized compensation cost, amortization period | 3 years 0 months 9 days | ||
Stock options | Special Cash Dividend | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation liability, current | 31,738,000 | 31,738,000 | 39,922,000 |
Stock-based compensation liability, noncurrent | 0 | 0 | 25,966,000 |
Stock-based compensation liability, current and noncurrent | 31,738,000 | 31,738,000 | 65,888,000 |
Stock options | Special Cash Dividend | EIP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based compensation arrangement, plan modification, incremental compensation cost recognized in period | 100,000 | ||
Share-based compensation arrangement, plan modification, incremental compensation cost, deferred | 600,000 | 600,000 | |
Share-based compensation arrangement, plan modification, incremental compensation cost, deferred, recognition period | 2 years 6 months | ||
Stock-based compensation liability, current | 3,703,000 | 3,703,000 | 3,675,000 |
Stock-based compensation liability, noncurrent | 0 | 0 | 0 |
Stock-based compensation liability, current and noncurrent | 3,703,000 | 3,703,000 | 3,675,000 |
Unrecorded stock-based compensation liability, current and noncurrent | 4,600,000 | 4,600,000 | 7,200,000 |
Unrecognized compensation cost, amortization period | 4 years 3 months | ||
Stock options | Special Cash Dividend | Rollover Options | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation liability, current | 28,035,000 | 28,035,000 | 36,247,000 |
Stock-based compensation liability, noncurrent | 0 | 0 | 25,966,000 |
Stock-based compensation liability, current and noncurrent | 28,035,000 | 28,035,000 | 62,213,000 |
Unrecorded stock-based compensation liability, current and noncurrent | $0 | $0 | $0 |
Fair_Value_Measurements_Detail
Fair Value Measurements (Details) (USD $) | 3 Months Ended | |
Dec. 31, 2014 | Mar. 31, 2014 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $9,000,000 | |
Fair Value Assumptions, Expected Volatility Rate | 30.00% | |
Fair Value, Measurements, Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 197,443,000 | 259,994,000 |
Fair Value, Measurements, Recurring | Cash and cash equivalents | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 48,005,000 | 37,886,000 |
Fair Value, Measurements, Recurring | Money market fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 149,438,000 | 222,108,000 |
Fair Value, Measurements, Recurring | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 48,005,000 | 37,886,000 |
Fair Value, Measurements, Recurring | Level 1 | Cash and cash equivalents | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 48,005,000 | 37,886,000 |
Fair Value, Measurements, Recurring | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 149,438,000 | 222,108,000 |
Fair Value, Measurements, Recurring | Level 2 | Money market fund | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total cash and cash equivalents | 149,438,000 | 222,108,000 |
Fair Value, Measurements, Recurring | Level 3 | Liability | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Business Combination, Contingent Consideration, Liability, Noncurrent | $4,500,000 |
RelatedParty_Transactions_Deta
Related-Party Transactions (Details) (USD $) | 0 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Nov. 05, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Jul. 31, 2008 | |
Related Party Transactions [Abstract] | |||||||
Repurchase of common stock | 1,000,000 | 1,377,001 | 203,782 | ||||
Repurchase of common stock, price per share | $25.10 | ||||||
Revenue associated with related parties | $312,000 | $70,000 | $961,000 | $237,000 | |||
Cost associated with related parties | 233,000 | 61,000 | 719,000 | 201,000 | |||
Lender syndicate, outstanding debt amount | 47,000,000 | 47,000,000 | 55,500,000 | ||||
Management agreement, annual fee | 1,000,000 | ||||||
Management agreement, advisory fees | $250,000 | $250,000 | $750,000 | $750,000 |
Commitments_and_Contingencies_
Commitments and Contingencies (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||
In Millions, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Jul. 31, 2008 | Mar. 31, 2014 |
leases | ||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||
Number of facility leases assigned to Booz & Co | 9 | |||||
Number of facility leases assigned to Booz & Co., outstanding | 2 | 2 | ||||
Maximum potential amount of undiscounted future lease payments | 10.6 | 10.6 | ||||
Unfavorable Regulatory Action | ||||||
Loss Contingencies [Line Items] | ||||||
Liability for reductions and/or penalties from U.S Governement audits | 200 | 200 | $189.80 | |||
Contracts with U.S. government agencies or other U.S. government contractors | ||||||
Concentration Risk [Line Items] | ||||||
Concentration risk, percentage | 97.00% | 98.00% | 98.00% | 98.00% |
Commitments_and_Contingencies_1
Commitments and Contingencies (Litigation) (Details) (USD $) | 9 Months Ended | 12 Months Ended | 18 Months Ended | 57 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2014 | Mar. 31, 2014 | Dec. 15, 2009 | Dec. 31, 2014 | Jul. 02, 2010 |
plaintiffs | claims | claims | |||
claims | |||||
Legal proceedings and investigations arising in the ordinary course of business | Maximum | |||||
Loss Contingencies [Line Items] | |||||
Loss contingencies, damages sought, value | $40 | ||||
Former stockholder litigation | |||||
Loss Contingencies [Line Items] | |||||
Loss contingencies, number of plaintiffs | 6 | ||||
Loss contingencies, new claims filed, number | 9 | ||||
Loss contingencies, claims amended, number | 3 | ||||
Loss contingencies, claims dismissed, number | 3 | ||||
Loss contingencies, damages sought, value | 348.7 | 348.7 | |||
Former stockholder litigation | United States District Court for the Southern District of New York | |||||
Loss Contingencies [Line Items] | |||||
Loss contingencies, pending claims, number | 5 | 5 | |||
Former stockholder litigation | United States Court of Appeals for the Ninth Circuit | |||||
Loss Contingencies [Line Items] | |||||
Loss contingencies, pending claims, number | 1 | 1 | |||
Former stockholder litigation | RICO | |||||
Loss Contingencies [Line Items] | |||||
Loss contingencies, damages sought, value | $291.50 | $291.50 |
Subsequent_Events_Subsequent_E1
Subsequent Events Subsequent Events (Details) (USD $) | Dec. 31, 2014 | Jan. 27, 2015 |
In Millions, unless otherwise specified | ||
Subsequent Event [Line Items] | ||
Stock Repurchase Program, Authorized Amount | $30 | |
Subsequent Event | ||
Subsequent Event [Line Items] | ||
Stock Repurchase Program, Authorized Amount | $180 |